Skip to main content
. 2009 May 2;1:10. doi: 10.1186/1758-3284-1-10

Table 3.

Distribution of patients with their Histopathological findings and habits

Histological Findings No of patients
N = 239
Habits No of Patients Male
N = 204
Female
N = 35
Frequency/Day Duration (Years)
OSMF I 52 (21.8%) Chewing (Areca Nut/Dohra) 20 (38.5%) 17 (85%) 3 (15%) 3–4 3–4 yrs

Gutka 10 (19.2%) 9 (90%) 1 (10%) 2–3 2–4 yrs

Betel quid with areca nut and tobacco 7 (13.5%) 4 (57.2%) 3 (42.8%) 2–4 4–5 yrs

Smoking
(Bidi/Cigarettes/Pipes
5 (11.1%) 5 (100%) 0 (0%) 5–10 >5 yrs

Alcohol 0 (0%) 0 (0%) 0 (0%) 0 0

Chewing + Smoking 5 (9.6%) 4 (80%) 1 (20%) 2–5/ 3–4 yrs

Alcohol+ Chewing 3 (5.8%) 3 (100%) 0 (0%) 1–3 2–3 yrs

Alcohol+ Smoking 2 (3.6%) 2 (100%) 0 (0%) 2–5 4–5 yrs

OSMF II 75
(31. 4%)
Chewing (Areca Nut/Dohra) 30 (40%) 24 (80%) 6 (20%) 7–10 8–10 yrs

Gutka 16 (21.3%) 11(68.8%) 5 (31.2%) 5–6 7–10 yrs

Betel quid with areca nut and tobacco 11 (14.7%) 7 (63.7%) 4 (36.3%) 6–9 6–7 yrs

Smoking (Bidi/Cigarettes/Pipes) 6 (8%) 6 (100%) 0 (0%) 8–10 7–9 yrs

Alcohol 1 (1.3%) 1 (100%) 0 (0%) 2–3 6–7

Chewing + Smoking 4 (5.3%) 3 (75%) 1 (25%) 4–8 6–8 yrs

Alcohol+ Chewing 3 (4%) 3 (100%) 0 (0%) 3–8 7–10 yrs

Alcohol+ Smoking 3 (4%) 3 (100%) 0 (0%) 4–7 8–10 yrs

None 1 (1.4%) 1 (100%) 0 (0%)

OSMF III 112 (46.8%) Chewing(Areca Nut/Dohra) 60 (53.5%) 54 (90%) 6 (10%) 10–15 10–17 yrs
Gutka 23 (20.4%) 21(91.3%) 2(8.7%) 8–10 7–10 yrs

Betel quid with areca nut and tobacco 20
(18%)
17 (85%) 3 (15%) 7–9 7–9 yrs

Smoking (Bidi/Cigarettes/Pipes) 3(2.7%) 3 (100%) 0 (0%) 8–10 9–10 yrs

Alcohol 1(0.9%) 1 (100%) 0 (0%) 4–5 7–10

Chewing + Smoking 2(1.8%) 2 (100%) 0 (0%) 6–9 8–10 yrs

Alcohol+ Chewing 1(0.9%) 1 (100%) 0 (0%) 4–8 7– 9 yrs

Alcohol+ Smoking 2(1.8%) 2 (100%) 0 (0%) 6–9 8–10 yrs
HHS Vulnerability Disclosure